This is a preview of subscription content, log in via an institution to check access.
Reference
Arbel R, et al. Usefulness of Sodium-Glucose Cotransporter 2 Inhibitors for Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus. . American Journal of Cardiology : 15 May 2021. Available from: URL: http://doi.org/10.1016/j.amjcard.2021.03.040
Rights and permissions
About this article
Cite this article
Empagliflozin least costly option for preventing heart failure in T2DM patients?. PharmacoEcon Outcomes News 879, 10 (2021). https://doi.org/10.1007/s40274-021-7733-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7733-9